Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Treasury Shares (2018 - 2025)

Historic Treasury Shares for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to $1.5 million.

  • Verastem's Treasury Shares rose 3919.33% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 3919.33%. This contributed to the annual value of $1.0 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Verastem's Treasury Shares is $1.5 million, which was up 3919.33% from $1.5 million recorded in Q2 2025.
  • Verastem's 5-year Treasury Shares high stood at $2.9 million for Q2 2021, and its period low was $142333.0 during Q2 2023.
  • For the 5-year period, Verastem's Treasury Shares averaged around $1.6 million, with its median value being $1.6 million (2021).
  • In the last 5 years, Verastem's Treasury Shares tumbled by 9452.94% in 2023 and then surged by 67144.58% in 2024.
  • Verastem's Treasury Shares (Quarter) stood at $2.8 million in 2021, then tumbled by 93.84% to $172909.0 in 2022, then soared by 30.52% to $225675.0 in 2023, then soared by 347.65% to $1.0 million in 2024, then soared by 44.03% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $1.5 million for Q2 2025, and $1.8 million during Q1 2025.